Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01247
|
|||||
Drug Name |
Citrate
|
|||||
Indication | Acute kidney injury [ICD11: GB60] | Preclinical | [1] | |||
Formula |
C6H8O7
|
|||||
Canonical SMILES |
C(C(=O)O)C(CC(=O)O)(C(=O)O)O
|
|||||
InChI |
InChI=1S/C6H8O7/c7-3(8)1-6(13,5(11)12)2-4(9)10/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)
|
|||||
InChIKey |
KRKNYBCHXYNGOX-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 77-92-9
|
|||||
Pharmaceutical Properties | Molecular Weight | 192.12 | Topological Polar Surface Area | 132 | ||
Heavy Atom Count | 13 | Rotatable Bond Count | 5 | |||
Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 7 | |||
XLogP |
-1.7
|
|||||
PubChem CID | ||||||
ChEBI ID |
CHEBI:30769
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | NaCT | Transporter Info | Sodium-coupled citrate transporter | Substrate | [2] | |
References | ||||||
1 | ClinicalTrials.gov (NCT02194569) Magnesium Balance of Citrate-based Continuous Venovenous Hemofiltration, Effect of Citrate Dose. | |||||
2 | SLC13 family of Na+ coupled di- and tri-carboxylate/sulfate transporters. Mol Aspects Med. 2013 Apr-Jun;34(2-3):299-312. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.